| Pubmed | 8702798 |
| Title: | The CXC chemokines growth-regulated oncogene (GRO) alpha, GRObeta, GROgamma, neutrophil-activating peptide-2, and epithelial cell-derived neutrophil-activating peptide-78 are potent agonists for the type B, but not the type A, human interleukin-8 receptor. |
| Year: | 1996 |
| DOI: | https://doi.org/10.1074/jbc.271.34.20545 |
| First Author: | Ahuja |
| Experimental setup: | in vitro (Hprd)
in vivo (Hprd) |